When penile squamous cell carcinoma has spread to distant sites — classified as M1 disease — systemic palliative therapy becomes the central treatment strategy. This page outlines the clinical scenario and provides a partial overview of the evidence-based approach.
Distant metastatic penile squamous cell carcinoma (M1) encompasses disease that has disseminated beyond regional lymph nodes to distant organs or sites. At this stage, curative intent is not feasible, and the clinical focus shifts to palliative systemic control. Guidelines recommend platinum-based chemotherapy as the preferred approach to first-line palliative systemic therapy in this population.
First-line palliative treatment centres on platinum-based chemotherapy, with both combination and single-agent options available depending on patient suitability and performance status. Certain agents are specifically excluded from consideration in this setting because of unacceptable toxicity risk.